Physician profile
Jason David Tegethoff
NPI 1437784675
$3,707.06
in general payments reported to CMS, 2019-2025
7 companies · $726 in 2025
The $726 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $377 · 2022: $120 · 2023: $1,175 · 2024: $1,309 · 2025: $726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,210.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,007.65 | 2022-2025 | Gamma, Everest Spinal System, N/A |
| Medtronic, INC. | $390.62 | 2023-2025 | Mazor X System |
| Skeletal Dynamics INC | $377.09 | 2021 | |
| Medacta USA, INC. | $362.73 | 2023-2024 | Nextar Knee |
| Lightbody Medical Technologies INC | $204.66 | 2024-2025 | |
| Depuy Synthes Sales INC. | $203.29 | 2024-2025 | Velys, Teligen, Symphony |
| Medical Device Business Services, INC. | $161.02 | 2024-2025 | Fibergraft Aeridyan Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Tegethoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.